Document is current
Any future updates will be listed below
-
Authors
Stefanidou, Theodora
Ambler, Gareth
Bartl, Gergely
Barber, Nick
Billings, Jo
Bogatsu, Tumelo
Carroll, Richard
Chipp, Beverley
Conneely, Maev
Downey, Anne-Marie
Evlat, Gamze
Hunter, Rachael
Le Novere, Marie
Lewis, Glyn
Mackay, Tanya
Marwaha, Steven
Matin, Zubair
Naughton, Georgia
Nekitsing, Chandani
O’Sullivan, Millie
Pinfold, Vanessa
Pan, Shengning
Sobers, Angela
Thompson, Keith J.
Vasikaran, Jerusaa
Webber, Martin
Johnson, Sonia
Lloyd-Evans, Brynmor https://orcid.org/0000-0001-9866-788X
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR131647)
- License Information
-
More Information
Article History
Received: 29 July 2023
Accepted: 28 September 2023
First Online: 6 October 2023
Declarations
:
: The trial was approved by the South Central Oxford B Research Ethics Committee on 30th March 2022 (REC reference 22/SC/0064). Subsequent amendments to the trial protocol reported in this paper were also reviewed and approved by the Research Ethics Committee (see Additional file : Appendix 1 for details.)Written, informed consent to participate will be obtained from all participants.
: All participants will consent to publish results, both on a group level and individually, given adequate anonymisation. All data will be analysed with respect for confidentiality. This information is included in the Participant Information Sheets and consent will be given accordingly.
: The authors declare they have no competing interests.
